Cytosorbents (CTSO) Change in Acquisitions & Divestments (2015 - 2016)

Cytosorbents (CTSO) reported Change in Acquisitions & Divestments of $249000.0 for Q3 2016, down 83.33% on a YoY basis from $1.5 million in Q4 2015, and down 87.18% quarter-over-quarter from $1.9 million in Q2 2016.

Cytosorbents (CTSO) Change in Acquisitions & Divestments (2015 - 2016) Analysis & Trends

Cytosorbents has reported Change in Acquisitions & Divestments for 2 years, with the latest figure at $249000.0 in Q3 2016.

  • For the quarter ending Q3 2016, Change in Acquisitions & Divestments fell 83.33% year-over-year to $249000.0; the trailing twelve-month figure through Dec 2017 stood at $2.2 million (changed 0.0% YoY), and the FY2016 full-year result was $2.2 million, down 59.64% from the prior year.
  • Change in Acquisitions & Divestments for Q3 2016 stood at $249000.0, down from $1.9 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $1.9 million in Q2 2016, with the low at $249000.0 in Q3 2016.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 Cytosorbents 25.72 Mn 20.92 Mn 6.13 Mn

Historic Data

Download Data
DateValue
Sep 30, 2016 249,000.00
Sep 30, 2016 249,000.00
Jun 30, 2016 1.94 Mn
Jun 30, 2016 1.94 Mn
Dec 31, 2015 1.49 Mn
Dec 31, 2015 1.49 Mn
Sep 30, 2015 1.49 Mn
Sep 30, 2015 1.49 Mn
Jun 30, 2015 1.20 Mn
Jun 30, 2015 1.20 Mn
Mar 31, 2015 1.25 Mn
Mar 31, 2015 1.25 Mn